A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples